Skip to main content
. 2017 Jun 7;3:80. doi: 10.21037/jovs.2017.05.06

Table 1. Patient baseline characteristics and results of ICGF.

Variable Value
Age, yrs 65 [30–87]
Sex (male/female) 10/10
Disease
   Primary lung cancer 15
   Metastatic lung tumor 5
Smoking history
   Current/never 9/11
Pulmonary function
   FEV1, L 2.25 (1.28–4.02)
   COPD (FEV1% <70) 5
Tumor location
   Right S2/S3b/S6/S8/S8+9/S8a/7+10+9a 2/1/1/4/1/1/1
   Left upper division/upper division +S6/S6 6/1/2
Tumor size, mm 16 [9–32]
Operative duration, min 186 [90–319]
Intraoperative blood loss, mL 30 [0–107]
Intraoperative adverse events 0
Conversion to thoracotomy 0
Postoperative outcome (Clavien-Dindo classification)
   Grade 0 19
   Grade I 1a
Chest drainage, days 1 [1–3]
Hospitalization, days 5 [5–8]
ICGF
   Valid temporary/Invalid demarcation 19/1
   First appearance of ICGF, s 20 [10–100]
   Duration of ICGF, s 180 [90–300]
   Duration of effective contrast before spread into TSs, s 70 [30–116]
Surgical margin
   ≥ Tumor size 18
   < Tumor size 2

Data expressed as n (range) unless otherwise indicated. a, slight renal dysfunction. COPD, chronic obstructive pulmonary disease; FEV1, forced expiratory volume in 1 s; ICGF, indocyanine green fluorescence.